| Profile for travgoneswilanhitch |
|---|
|
SignatureApril 7, 2005. Drug giant Pfizer’s two blockbuster Cox-2 inhibitor drugs, Celebrex and Bextra, were both cited by the Food and Drug Administration for safety problems, particularly for long term users. Last Thursday the FDA allowed Pfizer to keep Celebrex on the market if it added the “black... |
